Market Overview

LifePoint (LPNT) Alert: Johnson Fistel Investigates Proposed Sale of LifePoint Health, Inc.; Is $65.00 a Fair Price?

Share:

LifePoint (LPNT) Alert: Johnson Fistel Investigates Proposed Sale of LifePoint Health, Inc.; Is $65.00 a Fair Price?

PR Newswire

SAN DIEGO, July 23, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of LifePoint Health, Inc. ("LifePoint") (NASDAQ:LPNT) breached their fiduciary duties in connection with the proposed sale of the Company to RCCH HealthCare Partners ("RCCH"). LifePoint owns and operates community hospitals, regional health systems, physician practices, outpatient centers, and post-acute facilities in the United States.

On July 23, 2018, LifePoint announced that it had signed a definitive merger agreement with RCCH. Under the terms of the transaction, LifePoint shareholders will receive $65.00 per share in cash for each share of LifePoint common stock they own.

The investigation concerns whether the LifePoint board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for LifePoint shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given Wall Street analysts' projections for LifePoint's future earnings and revenue growth. 

If you are a shareholder of LifePoint and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number.

About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit http://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.

Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
jimb@johnsonfistel.com

Cision View original content:http://www.prnewswire.com/news-releases/lifepoint-lpnt-alert-johnson-fistel-investigates-proposed-sale-of-lifepoint-health-inc-is-65-00-a-fair-price-300684716.html

SOURCE Johnson Fistel, LLP

View Comments and Join the Discussion!